Home > Publications Database > Association Between Obstructive Sleep Apnea and Brain White Matter Hyperintensities in a Population-Based Cohort in Germany. > print

001     162920
005     20240918164038.0
024 7 _ |a 10.1001/jamanetworkopen.2021.28225
|2 doi
024 7 _ |a pmid:34609493
|2 pmid
024 7 _ |a pmc:PMC8493431
|2 pmc
024 7 _ |a altmetric:114566235
|2 altmetric
037 _ _ |a DZNE-2021-01573
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Zacharias, Helena U
|b 0
245 _ _ |a Association Between Obstructive Sleep Apnea and Brain White Matter Hyperintensities in a Population-Based Cohort in Germany.
260 _ _ |a Chicago, Ill.
|c 2021
|b American Medical Association
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1726662751_23571
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a (CC BY)
520 _ _ |a Underlying pathomechanisms of brain white matter hyperintensities (WMHs), commonly observed in older individuals and significantly associated with Alzheimer disease and brain aging, have not yet been fully elucidated. One potential contributing factor to WMH burden is chronic obstructive sleep apnea (OSA), a disorder highly prevalent in the general population with readily available treatment options.To investigate potential associations between OSA and WMH burden.Analyses were conducted in 529 study participants of the Study of Health in Pomerania-Trend baseline (SHIP-Trend-0) study with complete WMH, OSA, and important clinical data available. SHIP-Trend-0 is a general population-based, cross-sectional, observational study to facilitate the investigation of a large spectrum of common risk factors, subclinical disorders, and clinical diseases and their relationships among each other with patient recruitment from Western Pomerania, Germany, starting on September 1, 2008, with data collected until December 31, 2012. Data analysis was performed from February 1, 2019, to January 31, 2021.The apnea-hypopnea index (AHI) and oxygen desaturation index (ODI) were assessed during a single-night, laboratory-based polysomnography measurement.The primary outcome was WMH data automatically segmented from 1.5-T magnetic resonance images.Of 529 study participants (mean [SD] age, 52.15 [13.58] years; 282 female [53%]), a total of 209 (40%) or 102 (19%) individuals were diagnosed with OSA according to AHI or ODI criteria (mean [SD] AHI, 7.98 [12.55] events per hour; mean [SD] ODI, 3.75 [8.43] events per hour). Both AHI (β = 0.024; 95% CI, 0.011-0.037; P <.001) and ODI (β = 0.033; 95% CI, 0.014-0.051; P <. 001) were significantly associated with brain WMH volumes. These associations remained even in the presence of additional vascular, metabolic, and lifestyle WMH risk factors. Region-specific WMH analyses found the strongest associations between periventricular frontal WMH volumes and both AHI (β = 0.0275; 95% CI, 0.013-0.042, P < .001) and ODI (β = 0.0381; 95% CI, 0.016-0.060, P < .001) as well as periventricular dorsal WMH volumes and AHI (β = 0.0165; 95% CI, 0.004-0.029, P = .008).This study found significant associations between OSA and brain WMHs, indicating a novel, potentially treatable WMH pathomechanism.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Aging: physiology
|2 MeSH
650 _ 2 |a Cohort Studies
|2 MeSH
650 _ 2 |a Cross-Sectional Studies
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Germany: epidemiology
|2 MeSH
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Magnetic Resonance Imaging: methods
|2 MeSH
650 _ 2 |a Magnetic Resonance Imaging: statistics & numerical data
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Sleep Apnea, Obstructive: complications
|2 MeSH
650 _ 2 |a Sleep Apnea, Obstructive: diagnostic imaging
|2 MeSH
650 _ 2 |a Sleep Apnea, Obstructive: epidemiology
|2 MeSH
650 _ 2 |a White Matter: abnormalities
|2 MeSH
650 _ 2 |a White Matter: physiopathology
|2 MeSH
700 1 _ |a Weihs, Antoine
|b 1
700 1 _ |a Habes, Mohamad
|0 P:(DE-2719)9000112
|b 2
|u dzne
700 1 _ |a Wittfeld, Katharina
|0 P:(DE-2719)2810491
|b 3
|u dzne
700 1 _ |a Frenzel, Stefan
|b 4
700 1 _ |a Rashid, Tanweer
|b 5
700 1 _ |a Stubbe, Beate
|b 6
700 1 _ |a Obst, Anne
|b 7
700 1 _ |a Szentkirályi, András
|b 8
700 1 _ |a Bülow, Robin
|b 9
700 1 _ |a Berger, Klaus
|b 10
700 1 _ |a Fietze, Ingo
|b 11
700 1 _ |a Penzel, Thomas
|b 12
700 1 _ |a Hosten, Norbert
|b 13
700 1 _ |a Ewert, Ralf
|b 14
700 1 _ |a Völzke, Henry
|b 15
700 1 _ |a Grabe, Hans
|0 P:(DE-2719)2811781
|b 16
|e Last author
|u dzne
773 _ _ |a 10.1001/jamanetworkopen.2021.28225
|g Vol. 4, no. 10, p. e2128225 -
|0 PERI:(DE-600)2931249-8
|n 10
|p e2128225
|t JAMA network open
|v 4
|y 2021
|x 2574-3805
856 4 _ |u https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2784763
856 4 _ |u https://pub.dzne.de/record/162920/files/DZNE-2021-01573.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/162920/files/DZNE-2021-01573.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:162920
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 2
|6 P:(DE-2719)9000112
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)2810491
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 16
|6 P:(DE-2719)2811781
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2021
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-03
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-03
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2021-02-03
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2021-02-03
915 _ _ |a Creative Commons Attribution-NonCommercial-NoDerivs CC BY-NC-ND (No Version)
|0 LIC:(DE-HGF)CCBYNCNDNV
|2 V:(DE-HGF)
|b DOAJ
|d 2021-02-03
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b JAMA NETW OPEN : 2021
|d 2022-11-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2022-11-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2022-11-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2021-10-18T13:36:16Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2021-10-18T13:36:16Z
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Blind peer review
|d 2021-10-18T13:36:16Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2022-11-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2022-11-16
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2022-11-16
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b JAMA NETW OPEN : 2021
|d 2022-11-16
920 1 _ |0 I:(DE-2719)5000001
|k AG Grabe
|l Biomarkers of Dementia in the General Population
|x 0
920 1 _ |0 I:(DE-2719)1510600
|k AG Hoffmann
|l Translational Health Care Research
|x 1
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)5000001
980 _ _ |a I:(DE-2719)1510600
980 _ _ |a UNRESTRICTED
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21